The Hill logo
Daily Caller logo
Newsmax logo
3 articles
·3M

Senate Confirms Dr. Marty Makary and Dr. Jay Bhattacharya to Lead Health Agencies

The Senate confirms Dr. Marty Makary and Dr. Jay Bhattacharya to lead the FDA and NIH, respectively, amidst controversy over their COVID-19 responses.

Overview

A summary of the key points of this story verified across multiple sources.

Dr. Marty Makary and Dr. Jay Bhattacharya were confirmed by the Senate to lead the FDA and NIH, respectively, with votes of 56-44 and 53-47. Both nominees have previously criticized the federal government's response to COVID-19 and are seen as pivotal in shaping health policy under Health and Human Services Secretary Robert F. Kennedy Jr. Makary, from Johns Hopkins, has emphasized the need for fresh leadership at the FDA, while Bhattacharya, a Stanford professor, aims to restore public trust in health institutions. Their confirmation reflects a broader shift in health policy priorities aligned with the Trump administration's agenda.

Content generated by AI—learn more or report issue.

Pano Newsletter

Get both sides in 5 minutes with our daily newsletter.

Analysis

Compare how each side frames the story — including which facts they emphasize or leave out.

  • Marty Makary's confirmation as FDA commissioner was passed with bipartisan support, reflecting some Democratic backing despite concerns from their party.
  • Makary must address contentious issues, including access to the abortion drug mifepristone and vaccine policy under a skeptical HHS Secretary.
  • His previous criticisms of COVID-19 policies indicate he may favor reevaluating current practices at the FDA, while emphasizing the importance of vaccines.

Articles (3)

Compare how different news outlets are covering this story.

Center (1)

No highlight available for this article.

Senate confirms Marty Makary to lead FDA
The HillThe Hill·3M·
Center
This outlet is balanced or reflects centrist views.

FAQ

Dig deeper on this story with frequently asked questions.

Dr. Marty Makary has expressed skepticism about vaccine policies during the pandemic but did not commit to specific changes in his confirmation hearing. He mentioned reassessing vaccine-related meetings and emphasized a generational opportunity to address health issues with a focus on 'common sense' and science.

Dr. Jay Bhattacharya aims to decentralize NIH research and prioritize projects with direct benefits to American health, while also emphasizing transparency and reducing 'frivolous' research. He has advocated for a more inclusive environment that welcomes diverse viewpoints.

The confirmations of Dr. Makary and Dr. Bhattacharya align with the Trump administration's agenda by introducing more conservative health policies. Both nominees have been vocal critics of previous COVID-19 policies, promising changes in leadership and approach at the FDA and NIH.

History

See how this story has evolved over time.

  • This story does not have any previous versions.